Analysis of polymorphisms in the promoter region and protein levels of interleukin-6 gene among gout patients

Clinical and Experimental Rheumatology

Volumn 26, Issue 5, 2008, Pages 841-847

  Tsai, Pei Chien ^a   Chen, Chung Jen ^b   Lai, Han Ming ^b   Chang, Shun Jen ^c  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b Division of Pediatric Allergy Immunology and Rheumatology   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Gout; Interleukin 6; Polymorphism promoter

Indexed keywords

BIOLOGICAL MARKER; CHOLESTEROL; CREATININE; INTERLEUKIN 6; TRIACYLGLYCEROL; URIC ACID;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE DURATION; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GOUT; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL;

ADULT; AGED; CASE-CONTROL STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GOUT; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 57249108551     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. DALBETH N, HASKARD DO: Mechanisms of inflammation in gout. Rheumatology (Oxford) 2005; 44: 1090-6.
2. WIGMORE SJ, FEARON KC, MAINGAY JP et al.: Interleukin-8 can mediate acute-phase protein production by isolated human hepatocytes. Am J Physiol 1997; 273: E720-6.
3. BAUMANN H, GAULDIE J: The acute phase response, Immunol Today 1994; 15: 74-80.
4. LIPSKY PE: Interleukin-6 and rheumatic diseases. Arthritis Res Ther 2006; 8 (Suppl. 2): S4.
5. DE BENEDETTI F, MASSA M, ROBBIONI P et al.: Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis. Arthritis Rheum 1991; 34: 1158-63.
6. LEPORE L, PENNESI M, SALETTA S et al.: Study of IL-2, IL-6, TNF alpha, IFN gamma and beta in the serum and synovial fluid of patients with juvenile chronic arthritis. Clin Exp Rheumatol 1994; 12: 561-5.
7. ACALOVSCHI D, WIEST T, HARTMANN M et al.: Multiple levels of regulation of the interleukin-6 system in stroke. Stroke 2003; 34: 1864-9.
8. KOMATSU Y, TAI H, GALICIA JC et al.: Interleukin-6 (IL-6) - 373 A9T11 allele is associated with reduced susceptibility to chronic periodontitis in Japanese subjects and decreased serum IL-6 level. Tissue Antigens 2005; 65: 110-4.
9. FISHMAN D, FAULDS G, JEFFERY R et al.: The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998; 102: 1369-76.
10. DESSEIN PH, JOFFE BI: Suppression of circulating interleukin-6 concentrations is associated with decreased endothelial activation in rheumatoid arthritis. Clin Exp Rheumatol 2006; 24: 161-7.
11. LIN KC, LIN HY, CHOU P: Community based epidemiological study on hyperuricemia and gout in Kin-Hu, Kinmen. J Rheumatol 2000; 27: 1045-50.
12. CHANG SJ, TSAI PC, CHEN CJ et al.: The polymorphism -863C/A in tumor necrosis factor alpha gene contributes an independent association to gout disease. Rheumatology 2007; 46: 1662-6.
13. CHEN ML, TSAI FJ, TSAI CH et al.: Tumor necrosis factor-alpha and interleukin-4 gene polymorphisms in Chinese patients with gout. Clin Exp Rheumatol 2007; 25: 385-9.
14. CHENG LS, CHIANG SL, TU HP et al.: Genomewide scan for gout in Taiwanese Aborigines reveals linkage to chromosome 4q25. Am J Hum Genet 2004; 75: 498-503.
15. WANG WH, CHANG SJ, WANG TN et al.: Complex segregation and linkage analysis of familial gout in Taiwanese aborigines. Arthritis Rheum 2004; 50: 242-6.
16. VAZQUEZ-MELLADO J, JIMENEZ-VACA AL, CUEVAS-COVARRUBIAS S et al: Molecular analysis of the SLC22A12 (URAT1) gene in patients with primary gout. Rheumatology (Oxford) 2007; 46: 215-9.
17. GUERNE PA, TERKELTAUB R, ZURAW B et al.: Inflammatory microcrystals stimulate interleukin-6 production and secretion by human monocytes and synoviocytes. Arthritis Rheum 1989; 32: 1443-52.
18. CHAI Z, GATTI S, TONIATTI C et al.: Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL-1 beta: A study on IL-6-deficient mice. J Exp Med 1996; 183: 311-6.
19. STREETZ KL, WUSTEFELD T, KLEIN C et al.: Mediators of inflammation and acute phase response in the liver. Cell Mol Biol (Noisyle-Grand) 2001; 47: 661-73.
20. DESGEORGES A, GABAY C, SILACCI P et al.: Concentrations and origins of soluble interleukin 6 receptor-alpha in serum and synovial fluid. J Rheumatol 1997; 24: 1510-6.
21. PAIK JK, KIM OY, KOH SJ et al.: Additive effect of interleukin-6 and C-reactive protein (CRP) single nucleotide polymorphism on serum CRP concentration and other cardiovascular risk factors. Clin Chim Acta 2007; 380: 68-74.
22. RYAN GB, MAJNO G: Acute inflammation. A review. Am J Pathol 1977; 86: 183-276.
23. MELNICOFF MJ, HORAN PK, MORAHAN PS: Kinetics of changes in peritoneal cell populations following acute inflammation. Cell Immunol 1989; 118: 178-91.
24. DOHERTY DE, DOWNEY GP, WORTHEN GS et al.: Monocyte retention and migration in pulmonary inflammation. Requirement for neutrophils. Lab Invest 1988; 59: 200-13.
25. ROMANO M, SIRONI M, TONIATTI C et al.: Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 1997; 6: 315-25.
26. MIHARA M, MORIYA Y, KISHIMOTO T et al.: Interleukin-6 (IL-6) induces the proliferation of synovial fibroblastic cells in the presence of soluble IL-6 receptor. Br J Rheumatol 1995; 34: 321-5.
27. TAMURA T, UDAGAWA N, TAKAHASHI N et al.: Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc Natl Acad Sci USA 1993; 90: 11924-8.
28. PEAKE NJ, KHAWAJA K, MYERS A et al.: Interleukin-6 signalling in juvenile idiopathic arthritis is limited by proteolytically cleaved soluble interleukin-6 receptor, Rheumatology (Oxford) 2006; 45: 1485-9.
29. TREJAUT JA, TSAI ZU, LEE HL et al.: Cytokine gene polymorphisms in Taiwan. Tissue Antigens 2004; 64: 492-9.
30. NAKAJIMA T, OTA N, YOSHIDA H et al.: Allelic variants in the interleukin-6 gene and essential hypertension in Japanese women. Genes Immun 1999; 1: 115-9.
31. LIM CS, ZHENG S, KIM YS et al.: The -174 G to C polymorphism of interleukin-6 gene is very rare in Koreans. Cytokine 2002; 19: 52-4.